سعر ديورازاك أسبوعي 90 مجم 4 كبسولات ممتدة المفعول 2022

Durazac weekly 90mg 4 delayed release caps — Fluoxetine (Biopharm Egypt > Andalous Pharma).

• Major depressive disorder and other labeled SSRI indications for fluoxetine; weekly 90 mg delayed-release presentation is intended for maintenance after patient stabilized on daily fluoxetine (typically 20 mg/day) — confirm Egyptian Durazac Weekly SmPC.Population: AdultsDailyMed (NLM)

• Do not use with MAOIs (including linezolid/IV methylene blue) within contraindicated washout windows; hypersensitivity to fluoxetine; do not use with pimozide or thioridazine (US fluoxetine label).General active-ingredient information · DailyMed (NLM)

• Boxed warning: antidepressants increase risk of suicidal thoughts/behaviors in children, adolescents and young adults — monitor. Serotonin syndrome risk with other serotonergic drugs. Activation of mania/hypomania. Abnormal bleeding with NSAIDs/aspirin/warfarin. Hyponatremia. Seizures. Long half-life — washout considerations (US fluoxetine label).General active-ingredient information · DailyMed (NLM)

• MAOIs; serotonergic drugs; QT-prolonging agents; CYP2D6 substratesMajorMAOIs, other serotonergic agents, drugs that prolong QT (e.g. thioridazine, pimozide), highly protein-bound drugs, and CYP2D6 substrates — clinically important interactions (US fluoxetine label). Management: Respect MAOI washouts; avoid contraindicated combinations; monitor (US label).DailyMed (NLM)

• Third-trimester SSRI exposure associated with persistent pulmonary hypertension of the newborn and neonatal adaptation syndrome; weigh risks/benefits. Pregnancy registry exists for antidepressants (US fluoxetine label).General active-ingredient information · DailyMed (NLM)

• Fluoxetine: Exact mechanism unknown; presumed to be linked to inhibition of CNS neuronal uptake of serotonin (US label).